9 products found
T2 Biosystems, Inc. Products
-
T2Dx Instrument
-
T2Bacteria - Sepsis - Causing Bacteria Panel
The T2Bacteria® Panel is the first and only FDA-cleared test to identify sepsis-causing bacteria directly from whole blood without the wait for blood ...
-
T2Candida - Candida Pathogen Detection Panel
The T2Candida® Panel is the first and only FDA-cleared direct-from-blood fungal pathogen detection assay, providing same-day results directly from a whole blood specimen for the most clinically relevant ...
-
T2SARS-CoV-2 - SARS-CoV-2 Direct Detection Panel
The T2SARS-CoV-2 Panel, run on the T2Dx® Instrument, is a qualitative reverse transcriptase-polymerase chain reaction (RT-PCR) and T2 Magnetic Resonance (
-
T2Resistance - Blood Detection Panel for Antimicrobial Resistance Markers
The first direct-from-blood detection of resistance markers: The T2Resistance® Panel is designed for the direct-from-blood detection of antibiotic resistance genes associated with sepsis-causing pathogens. The Panel detects many of the resistance mechanisms described in the 2013 CDC Urgent Threat list. In 2019, the FDA
-
T2Dx Instrument
The FDA-cleared and CE-marked T2Dx® Instrument is a fully automated, walk away, clinical multiplex benchtop diagnostic system capable of running tests directly from whole ...
-
T2MR Technology
T2MR® technology powers all of the diagnostic innovations at T2 Biosystems. T2MR is a diagnostic detection method utilizing miniaturized magnetic resonance technology which measures how water molecules react in the presence of magnetic fields. Over 200 studies published in peer-reviewed journals have featured T2MR in a breadth of applications, including direct detection and ...
-
Product Pipeline
-
Model T2Lyme Panel - Accurate and Timely Diagnosis
The T2Lyme™ Panel is designed to provide greater accuracy in the diagnosis of early Lyme disease, which may help improve care and lead to better patient outcomes, The T2Lyme™ Panel identifies the bacteria that cause Lyme disease directly from a patient’s blood. T2Lyme runs on the FDA-cleared T2Dx® Instrument, the same instrument currently used to run the FDA-cleared and CE marked
-
Model T2Cauris Panel RUO - Direct Detection of Emerging Superbug in Patient Skin and Blood Samples
The T2Cauris™ Panel RUO provides direct detection of the emerging superbug Candida auris in patient skin and patient blood and is now available for research use. The Centers for Disease Control and Prevention (CDC) validated the T2Cauris™ Panel RUO swab test on patient skin samples and published their findings in ...
-
T2Biothreat Panel
Detection of biothreat pathogens in 3-5 hours— direct from whole blood: The T2Biothreat® Panel, which runs on the T2Dx® Instrument, is a direct-from-blood test panel that provides results in 3-5 hours and simultaneously detects six biothreat pathogens identified as threats by the U.S. Government, including B. anthracis, ...